在外围神经瘤中的替代驱动路径 - 包括DICER1和/或KRAS的改变
Hsin-Yi Chang1,2, Carla Saoud2, Dianne Torrence3
1Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
The Journal of pathology
|January 23, 2025
概括
DICER1突变瘤可以模仿恶性外围神经膜瘤 (MPNSTs),特别是当KRAS突变存在时. 这项研究确定了一组具有DICER1和/或KRAS变化的MPNST子集,与传统的MPNST不同.
科学领域:
- 在瘤学瘤学.
- 遗传学 是一个遗传学.
- 病理学 病理学 病理学
背景情况:
- 与DICER1相关的瘤是一种新兴的瘤群,其特征是DICER1突变.
- 同时发生的基因变化,如TP53无活化和RAS通路激活在这些瘤中很常见.
- 类似于恶性外周神经膜瘤 (MPNSTs) 的瘤在DICER1瘤中很少被报告,并且存在诊断挑战.
研究的目的:
- 研究MPNST中DICER1和KRAS突变的发生率.
- 为了比较MPNSTs与DICER1-突变肉瘤的基因组和形态特征.
- 描述与DICER1和/或KRAS变化相关的MPNSTs的特定子集.
主要方法:
- 对DICER1,KRAS,ATRX,TP53,NF1和NF2在MPNST和DICER1突变肉瘤中的改变进行分子数据库分析.
- 瘤样本的形态评估.
- 基于DNA的甲基化分析.
主要成果:
- 确定了三例MPNST与同时存在的DICER1,ATRX和KRAS G12V/A变化的病例.
- 在38例 (21%) DICER1相关的瘤中,有8例携带二次KRAS热点突变,其中3例表现出类似MPNST的组织学.
- 具有TP53突变的DICER1突变肉瘤 (10/38,26%) 显示出多态表型,与KRAS突变肉瘤中的单态细胞形成鲜明对比.
结论:
- 存在与DICER1和/或KRAS突变相关的MPNSTs的一个独特子集.
- 这些MPNST缺乏正规的NF1 / NF2改变,并表现出单态螺旋细胞形态.
- 需要进一步的研究来澄清这些MPNST和传统MPNST之间的关系.
关键词:
ATRX ATRX 在线观看DICER1 的意思是说.克拉斯 (Kras) 是一个国家.MPNST MPNST 的意思是这就是TP53的特点.甲基化处理 甲基化处理周围神经罩瘤是周围神经罩的瘤.更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.1K
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
1.6K
相关概念视频
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Ras Gene
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Ras is a superfamily...
Loss of Tumor Suppressor Gene Functions
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Small GTPases - Ras and Rho
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
